Product Description
For mild to moderate acne vulgaris (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01494285)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Unknown
Route of Administration: Topical
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: M. Arkin 1999
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Acne Vulgaris
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01494285 |
MA1001 | P2 |
Completed |
Acne Vulgaris |
2013-10-01 |
2021-05-20 |
Primary Endpoints|Treatments |
Recent News Events
Date |
Type |
Title |
|---|